$108 Million is the total value of Velan Capital Investment Management LP's 32 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 51.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JASPER THERAPEUTICS INC | $14,848,445 | -24.3% | 11,219,036 | 0.0% | 13.79% | -17.6% | ||
| ADMA | Sell | ADMA BIOLOGICS INC | $10,059,128 | -24.0% | 2,726,051 | -31.8% | 9.34% | -17.2% |
| LNTH | Sell | LANTHEUS HLDGS INC | $8,392,000 | -32.2% | 100,000 | -33.3% | 7.79% | -26.2% |
| TELA | TELA BIO INC | $7,557,861 | -4.8% | 746,087 | 0.0% | 7.02% | +3.7% | |
| PRAX | PRAXIS PRECISION MEDICINES I | $5,962,750 | +42.2% | 5,185,000 | 0.0% | 5.54% | +54.8% | |
| HRTX | HERON THERAPEUTICS INC | $5,220,000 | -23.2% | 4,500,000 | 0.0% | 4.85% | -16.3% | |
| QIPT | Buy | QUIPT HOME MEDICAL CORP | $5,179,800 | -7.6% | 970,000 | +21.2% | 4.81% | +0.6% |
| Buy | ALIMERA SCIENCES INC | $4,846,190 | +795.3% | 1,659,654 | +543.9% | 4.50% | +876.1% | |
| OPTN | Buy | OPTINOSE INC | $4,424,139 | -34.4% | 3,596,861 | +2.9% | 4.11% | -28.6% |
| THC | TENET HEALTHCARE CORP | $4,223,622 | +37.0% | 51,900 | 0.0% | 3.92% | +49.2% | |
| IMGN | New | IMMUNOGEN INC | $3,575,865 | – | 189,500 | +100.0% | 3.32% | – |
| CABA | CABALETTA BIO INC | $3,227,500 | +56.1% | 250,000 | 0.0% | 3.00% | +70.1% | |
| GRTX | GALERA THERAPEUTICS INC | $3,120,000 | +21.9% | 1,000,000 | 0.0% | 2.90% | +32.8% | |
| PNT | Sell | POINT BIOPHARMA GLOBAL INC | $3,107,000 | -13.5% | 342,936 | -30.6% | 2.88% | -5.8% |
| Buy | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $2,820,300 | +463.5% | 55,300 | +136.3% | 2.62% | +513.3% | |
| GERN | Buy | GERON CORP | $2,498,985 | +283.9% | 778,500 | +159.5% | 2.32% | +318.0% |
| NSPR | New | INSPIREMD INC | $2,269,113 | – | 904,029 | +100.0% | 2.11% | – |
| CTLT | CATALENT INC | $2,168,000 | -34.0% | 50,000 | 0.0% | 2.01% | -28.1% | |
| ETNB | Sell | 89BIO INC | $1,800,250 | +20.0% | 95,000 | -3.6% | 1.67% | +30.7% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $1,689,600 | +25.7% | 240,000 | +9.1% | 1.57% | +36.9% |
| AVDL | Buy | AVADEL PHARMACEUTICALS PLCsponsored adr | $1,648,000 | +598.9% | 100,000 | +288.5% | 1.53% | +661.2% |
| ANNX | Buy | ANNEXON INC | $1,618,306 | +320.3% | 459,746 | +359.7% | 1.50% | +358.2% |
| Buy | ICOSAVAX INC | $1,595,056 | +83.3% | 160,630 | +7.1% | 1.48% | +99.6% | |
| EDSA | EDESA BIOTECH INC | $1,039,262 | -11.1% | 1,281,615 | 0.0% | 0.96% | -3.1% | |
| IFRX | New | INFLARX NV | $892,000 | – | 200,000 | +100.0% | 0.83% | – |
| RZLT | REZOLUTE INC | $792,000 | +3.1% | 400,000 | 0.0% | 0.74% | +12.2% | |
| ELEV | New | ELEVATION ONCOLOGY INC | $755,894 | – | 497,299 | +100.0% | 0.70% | – |
| INBX | New | INHIBRX INC | $649,000 | – | 25,000 | +100.0% | 0.60% | – |
| New | AIRSCULPT TECHNOLOGIES INCcall | $646,500 | – | 75,000 | +100.0% | 0.60% | – | |
| CGEM | New | CULLINAN ONCOLOGY INC | $538,000 | – | 50,000 | +100.0% | 0.50% | – |
| QIPT | New | QUIPT HOME MEDICAL CORPcall | $534,000 | – | 100,000 | +100.0% | 0.50% | – |
| BOLT | Exit | BOLT BIOTHERAPEUTICS INC | $0 | – | -140,000 | -100.0% | -0.17% | – |
| Exit | DISC MEDICINE INC | $0 | – | -12,269 | -100.0% | -0.22% | – | |
| COLL | Exit | COLLEGIUM PHARMACEUTICAL INC | $0 | – | -22,095 | -100.0% | -0.45% | – |
| CSU | Exit | SONIDA SENIOR LIVING INC | $0 | – | -82,832 | -100.0% | -0.48% | – |
| Exit | THESEUS PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.76% | – | |
| TERN | Exit | TERNS PHARMACEUTICALS INC | $0 | – | -120,000 | -100.0% | -1.21% | – |
| FEZ | Exit | SPDR INDEX SHS FDSput | $0 | – | -100,000 | -100.0% | -3.83% | – |
| IMCR | Exit | IMMUNOCORE HLDGS PLCads | $0 | – | -200,000 | -100.0% | -8.43% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LANTHEUS HLDGS INC | 8 | Q3 2023 | 18.0% |
| ADMA BIOLOGICS INC | 8 | Q3 2023 | 13.7% |
| JASPER THERAPEUTICS INC | 8 | Q3 2023 | 17.8% |
| TELA BIO INC | 8 | Q3 2023 | 7.6% |
| REZOLUTE INC | 8 | Q3 2023 | 1.3% |
| OPTINOSE INC | 7 | Q3 2023 | 7.9% |
| IMMUNOCORE HLDGS PLC | 6 | Q1 2023 | 13.7% |
| ALIMERA SCIENCES INC | 6 | Q3 2023 | 34.0% |
| QUIPT HOME MEDICAL CORP | 6 | Q3 2023 | 4.8% |
| SONIDA SENIOR LIVING INC | 6 | Q1 2023 | 2.5% |
View Velan Capital Investment Management LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-03-28 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-09 |
| SC 13D/A | 2024-02-09 |
| SC 13G/A | 2024-01-29 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-04 |
| 4 | 2023-08-17 |
| SC 13D/A | 2023-08-16 |
| 13F-HR | 2023-08-11 |
View Velan Capital Investment Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.